{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:59:38Z","timestamp":1782370778789,"version":"3.54.5"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Five pharmaceutical companies"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Depression, osteoporosis, and cardiovascular disease impose a heavy economic burden on society. Understanding economic impacts of suboptimal use of medication due to nonadherence and non-persistence (non-MAP) for these conditions is important for clinical practice and health policy-making.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>This systematic literature review aims to assess the impact of non-MAP to antidepressants, bisphosphonates and statins on healthcare resource utilisation and healthcare cost (HRUHC), and to assess how these impacts differ across medication classes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A systematic literature review and an aggregate meta-analysis were performed. Using the search protocol developed, PubMed, Cochrane Library, ClinicalTrials.gov, JSTOR and EconLit were searched for articles that explored the relationship between non-MAP and HRUHC (i.e., use of hospital, visit to healthcare service providers other than hospital, and healthcare cost components including medical cost and pharmacy cost) published from November 2004 to April 2021. Inverse-variance meta-analysis was used to assess the relationship between non-MAP and HRUHC when reported for at least two different populations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>Screening 1,123 articles left 10, seven and 13 articles on antidepressants, bisphosphonates, and statins, respectively. Of those, 27 were rated of good quality, three fair and none poor using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. In general, non-MAP was positively associated with HRUHC for all three medication classes and most prominently for bisphosphonates, although the relationships differed across HRUHC components and medication classes. The meta-analysis found that non-MAP was associated with increased hospital cost (26%, p = 0.02), outpatient cost (10%, p = 0.01), and total medical cost excluding pharmacy cost (12%, p&lt;0.00001) for antidepressants, and increased total healthcare cost (3%, p = 0.07) for bisphosphonates.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This systematic literature review is the first to compare the impact of non-MAP on HRUHC across medications for three prevalent conditions, depression, osteoporosis and cardiovascular disease. Positive relationships between non-MAP and HRUHC highlight inefficiencies within the healthcare system related to non-MAP, suggesting a need to reduce non-MAP in a cost-effective way.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0269836","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T17:23:05Z","timestamp":1656523385000},"page":"e0269836","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["A systematic review and meta-analysis on impact of suboptimal use of antidepressants, bisphosphonates, and statins on healthcare resource utilisation and healthcare cost"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-7885","authenticated-orcid":true,"given":"Kyu Hyung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-2401","authenticated-orcid":true,"given":"Leonie","family":"Tickle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"9","key":"pone.0269836.ref001","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","article-title":"Patient adherence and medical treatment outcomes: a meta-analysis","volume":"40","author":"MR DiMatteo","year":"2002","journal-title":"Medical care"},{"issue":"8","key":"pone.0269836.ref002","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1592\/phco.2005.25.8.1035","article-title":"Cardiovascular morbidity associated with nonadherence to statin therapy.","volume":"25","author":"DF Blackburn","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"1","key":"pone.0269836.ref003","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1742-1241.2007.01630.x","article-title":"The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review","volume":"62","author":"JA Cramer","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"2","key":"pone.0269836.ref004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/pds.3936","article-title":"Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes","volume":"25","author":"MJ Korhonen","year":"2016","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"pone.0269836.ref005","article-title":"Adherence to antidepressants and healthcare resource utilization and costs among medicare advantage beneficiaries with Parkinson\u2019s disease and depression","author":"Y-L Ling","year":"2016"},{"issue":"1","key":"pone.0269836.ref006","doi-asserted-by":"crossref","first-page":"e016982","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"RL Cutler","year":"2018","journal-title":"BMJ open"},{"issue":"11","key":"pone.0269836.ref007","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/bcp.14075","article-title":"The association between medication non\u2010adherence and adverse health outcomes in ageing populations: A systematic review and meta\u2010analysis","volume":"85","author":"CA Walsh","year":"2019","journal-title":"British journal of clinical pharmacology"},{"issue":"4","key":"pone.0269836.ref008","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ejhpharm-2018-001725","article-title":"Medication adherence interventions and outcomes: an overview of systematic reviews","volume":"26","author":"NC Wilhelmsen","year":"2019","journal-title":"European Journal of Hospital Pharmacy"},{"issue":"11","key":"pone.0269836.ref009","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1037\/hea0000778","article-title":"Positive affect and medication adherence in chronic conditions: A systematic review","volume":"38","author":"SM Bassett","year":"2019","journal-title":"Health Psychology"},{"key":"pone.0269836.ref010","volume-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003"},{"issue":"5","key":"pone.0269836.ref011","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"L Osterberg","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"4","key":"pone.0269836.ref012","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares","volume":"86","author":"MT Brown","year":"2011","journal-title":"Mayo Clinic proceedings"},{"key":"pone.0269836.ref013","author":"New England Healthcare Institute","year":"2009"},{"issue":"7","key":"pone.0269836.ref014","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ajhp\/60.7.657","article-title":"Meta-analysis of trials of interventions to improve medication adherence","volume":"60","author":"AM Peterson","year":"2003","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"6","key":"pone.0269836.ref015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication","volume":"62","author":"RC Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"pone.0269836.ref016","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00198-015-3164-4","article-title":"Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study","volume":"26","author":"P Hadji","year":"2015","journal-title":"Osteoporosis International"},{"key":"pone.0269836.ref017","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S2045796019000180","article-title":"The excess costs of depression: a systematic review and meta-analysis.","volume":"29","author":"H K\u00f6nig","year":"2019","journal-title":"Epidemiology and psychiatric sciences"},{"issue":"7","key":"pone.0269836.ref018","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1989.03430070062031","article-title":"The Functioning and Well-being of Depressed Patients: Results From the Medical Outcomes Study","volume":"262","author":"KB Wells","year":"1989","journal-title":"Jama"},{"issue":"2","key":"pone.0269836.ref019","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/11596880-000000000-00000","article-title":"Osteoporotic fractures: a systematic review of U.S. healthcare costs and resource utilization","volume":"30","author":"S Budhia","year":"2012","journal-title":"PharmacoEconomics"},{"issue":"2","key":"pone.0269836.ref020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"PE Greenberg","year":"2015","journal-title":"The Journal of clinical psychiatry"},{"key":"pone.0269836.ref021","volume-title":"Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015","author":"Australian Institute of Health and Welfare","year":"2019"},{"key":"pone.0269836.ref022","volume-title":"Preventing Costly Bone Fractures\u2014Why Don\u2019t We Do What Works","author":"R. Gagel","year":"2019"},{"issue":"12","key":"pone.0269836.ref023","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association","volume":"137","author":"EJ Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"pone.0269836.ref024","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.55.12.1121","article-title":"Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines","volume":"55","author":"HC Schulberg","year":"1998","journal-title":"Archives of general psychiatry"},{"issue":"2","key":"pone.0269836.ref025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clinthera.2010.02.004","article-title":"Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy","volume":"32","author":"G Corrao","year":"2010","journal-title":"Clinical therapeutics"},{"issue":"4","key":"pone.0269836.ref026","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes","volume":"288","author":"CA Jackevicius","year":"2002","journal-title":"Jama"},{"issue":"2","key":"pone.0269836.ref027","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4088\/PCC.v09n0202","article-title":"A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences.","volume":"9","author":"VM Hunot","year":"2007","journal-title":"Primary care companion to the Journal of clinical psychiatry"},{"issue":"suppl","key":"pone.0269836.ref028","article-title":"American Psychiatric Association practice guideline for the treatment of patients with major depressive disorder","volume":"167","author":"A Gelenberg","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"1","key":"pone.0269836.ref029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"J Compston","year":"2017","journal-title":"Archives of osteoporosis"},{"issue":"4","key":"pone.0269836.ref030","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1734-1140(11)70602-8","article-title":"Novel mechanistic and clinical implications concerning the safety of statin discontinuation.","volume":"63","author":"M Jasi\u0144ska-Stroschein","year":"2011","journal-title":"Pharmacological reports: PR"},{"key":"pone.0269836.ref031","volume-title":"Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care","author":"Centre for Reviews and Dissemination","year":"2009"},{"issue":"4","key":"pone.0269836.ref032","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Annals of internal medicine"},{"issue":"542","key":"pone.0269836.ref033","first-page":"759","article-title":"Tips and tricks in performing a systematic review","volume":"57","author":"A Sayers","year":"2007","journal-title":"Br J Gen Pract"},{"key":"pone.0269836.ref034","volume-title":"Quality assessment tool for observational cohort and cross-sectional studies","author":"L National Heart","year":"2014"},{"issue":"6","key":"pone.0269836.ref035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40273-018-0642-5","article-title":"A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D","volume":"36","author":"I Buchholz","year":"2018","journal-title":"PharmacoEconomics"},{"key":"pone.0269836.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21679169.2020.1846783","article-title":"Adherence to home-based exercises and\/or activity advice in low back pain patients: a systematic review.","author":"B van Koppen","year":"2020","journal-title":"European Journal of Physiotherapy"},{"key":"pone.0269836.ref037","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2019"},{"key":"pone.0269836.ref038","article-title":"Cochrane Handbook for systematic reviews of interventions version 5.1.0 [updated march 2011].","author":"J Higgins","year":"2011","journal-title":"The Cochrane Collaboration"},{"key":"pone.0269836.ref039","unstructured":"The Cochrane Collaboration. Review Manager (RevMan). 5.4 ed2020."},{"issue":"4","key":"pone.0269836.ref040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.mlr.0000204287.82701.9b","article-title":"Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes","volume":"44","author":"CR Cantrell","year":"2006","journal-title":"Medical care"},{"issue":"10","key":"pone.0269836.ref041","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00198-008-0586-2","article-title":"Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization","volume":"19","author":"JA Sunyecz","year":"2008","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"4","key":"pone.0269836.ref042","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2337\/dc08-1311","article-title":"Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings","volume":"32","author":"BC Stuart","year":"2009","journal-title":"Diabetes care"},{"issue":"1","key":"pone.0269836.ref043","doi-asserted-by":"crossref","first-page":"43","DOI":"10.18553\/jmcp.2006.12.1.43","article-title":"Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.","volume":"12","author":"RL Robinson","year":"2006","journal-title":"Journal of managed care pharmacy: JMCP"},{"issue":"10","key":"pone.0269836.ref044","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1080\/03007995.2017.1347092","article-title":"Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder","volume":"33","author":"C Vega","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"pone.0269836.ref045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rmed.2017.06.002","article-title":"Adherence and healthcare utilization among older adults with COPD and depression","volume":"129","author":"JS Albrecht","year":"2017","journal-title":"Respiratory medicine"},{"issue":"2","key":"pone.0269836.ref046","doi-asserted-by":"crossref","first-page":"145","DOI":"10.18553\/jmcp.2005.11.2.145","article-title":"Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy\u2014results from a managed care administrative claims database.","volume":"11","author":"MT Eaddy","year":"2005","journal-title":"Journal of managed care pharmacy: JMCP"},{"key":"pone.0269836.ref047","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jad.2017.09.057","article-title":"Impact of initial medication non-adherence to SSRIs on medical visits and sick leaves","volume":"226","author":"I Aznar-Lou","year":"2018","journal-title":"J Affect Disord"},{"issue":"1\u20132","key":"pone.0269836.ref048","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2008.07.004","article-title":"Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population","volume":"115","author":"M Tournier","year":"2009","journal-title":"J Affect Disord"},{"issue":"21","key":"pone.0269836.ref049","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/archinte.165.21.2497","article-title":"Impact of antidepressant drug adherence on comorbid medication use and resource utilization","volume":"165","author":"W Katon","year":"2005","journal-title":"Archives of internal medicine"},{"issue":"5","key":"pone.0269836.ref050","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bone.2007.07.009","article-title":"Consequences of poor compliance with bisphosphonates","volume":"41","author":"BA Briesacher","year":"2007","journal-title":"Bone"},{"issue":"4","key":"pone.0269836.ref051","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1060028015626935","article-title":"Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy: Findings From a Real-World Data Analysis","volume":"50","author":"S Sharman Moser","year":"2016","journal-title":"The Annals of pharmacotherapy"},{"issue":"1","key":"pone.0269836.ref052","doi-asserted-by":"crossref","first-page":"56","DOI":"10.18553\/jmcp.2015.21.1.56","article-title":"Cost and consequences of noncompliance to oral bisphosphonate treatment","volume":"21","author":"DF Eisenberg","year":"2015","journal-title":"Journal of managed care & specialty pharmacy"},{"issue":"12","key":"pone.0269836.ref053","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1007\/s00198-016-3683-7","article-title":"Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries.","volume":"27","author":"J Kjellberg","year":"2016","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"10","key":"pone.0269836.ref054","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5414\/CPP44484","article-title":"Factors associated with healthcare utilization costs for statin therapy\u2014a pilot study in Hong Kong","volume":"44","author":"CW Cheng","year":"2006","journal-title":"International journal of clinical pharmacology and therapeutics"},{"issue":"2","key":"pone.0269836.ref055","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/MLR.0000000000000950","article-title":"Comparison of Pharmacy Claims and Electronic Pill Bottles for Measurement of Medication Adherence Among Myocardial Infarction Patients","volume":"57","author":"SJ Mehta","year":"2019","journal-title":"Medical care."},{"key":"pone.0269836.ref056","first-page":"12","article-title":"Impact of statin copayments on adherence and medical care utilization and expenditures","author":"TB Gibson","year":"2006","journal-title":"The American journal of managed care"},{"issue":"6","key":"pone.0269836.ref057","first-page":"459","article-title":"Is there a relationship between early statin compliance and a reduction in healthcare utilization","volume":"16","author":"RE Aubert","year":"2010","journal-title":"The American journal of managed care"},{"issue":"3","key":"pone.0269836.ref058","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1345\/aph.1P539","article-title":"Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes","volume":"45","author":"J Wu","year":"2011","journal-title":"The Annals of pharmacotherapy"},{"issue":"3","key":"pone.0269836.ref059","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/193229681200600311","article-title":"New bundled world: quality of care and readmission in diabetes patients","volume":"6","author":"JY Chen","year":"2012","journal-title":"Journal of diabetes science and technology"},{"issue":"7","key":"pone.0269836.ref060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.18553\/jmcp.2014.20.7.703","article-title":"Associations between statin adherence level, health care costs, and utilization","volume":"20","author":"Y Zhao","year":"2014","journal-title":"Journal of managed care & specialty pharmacy"},{"issue":"11","key":"pone.0269836.ref061","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.amjcard.2011.01.052","article-title":"Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations","volume":"107","author":"DG Pittman","year":"2011","journal-title":"The American journal of cardiology"},{"key":"pone.0269836.ref062","first-page":"149573","article-title":"Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study.","volume":"2015","author":"YC Li","year":"2015","journal-title":"Biomed Res Int"},{"issue":"4","key":"pone.0269836.ref063","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1475-6773.2011.01250.x","article-title":"Does medication adherence lower Medicare spending among beneficiaries with diabetes?","volume":"46","author":"B Stuart","year":"2011","journal-title":"Health services research"},{"issue":"5","key":"pone.0269836.ref064","doi-asserted-by":"crossref","first-page":"310","DOI":"10.18043\/ncm.75.5.310","article-title":"Patterns of medication adherence and health care utilization among patients with chronic disease who were enrolled in a pharmacy assistance program","volume":"75","author":"AW Roberts","year":"2014","journal-title":"North Carolina medical journal"},{"issue":"1","key":"pone.0269836.ref065","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1186\/s12913-020-05946-4","article-title":"Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs\u2014an analysis of real-world data","volume":"20","author":"F Kirsch","year":"2020","journal-title":"BMC health services research"},{"issue":"3","key":"pone.0269836.ref066","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3111\/13696998.2010.511050","article-title":"The 6-month persistence on SSRIs and associated economic burden","volume":"13","author":"L Ereshefsky","year":"2010","journal-title":"Journal of medical economics"},{"issue":"1","key":"pone.0269836.ref067","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1345\/aph.1K671","article-title":"Contrasting Measures of Adherence with Simple Drug Use, Medication Switching, and Therapeutic Duplication","volume":"43","author":"BC Martin","year":"2009","journal-title":"Annals of Pharmacotherapy"},{"issue":"5","key":"pone.0269836.ref068","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1176\/ps.2006.57.5.673","article-title":"Antidepressant adherence and medical resource use among managed care patients with anxiety disorders","volume":"57","author":"MB Stein","year":"2006","journal-title":"Psychiatric services (Washington, DC)."},{"issue":"1","key":"pone.0269836.ref069","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jep.12422","article-title":"The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK: a study of patient records from the UK Clinical Practice Research Datalink","volume":"22","author":"S Ferguson","year":"2016","journal-title":"Journal of evaluation in clinical practice"},{"key":"pone.0269836.ref070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bone.2015.04.022","article-title":"Analysis of osteoporosis treatment patterns with bisphosphonates and outcomes among postmenopausal veterans","volume":"78","author":"J LaFleur","year":"2015","journal-title":"Bone"},{"key":"pone.0269836.ref071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2015.12.029","article-title":"Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review","volume":"193","author":"SC Ho","year":"2016","journal-title":"J Affect Disord"},{"issue":"7","key":"pone.0269836.ref072","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1185\/03007995.2016.1170673","article-title":"Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review.","volume":"32","author":"E Nguyen","year":"2016","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"pone.0269836.ref073","doi-asserted-by":"crossref","first-page":"223","DOI":"10.18553\/jmcp.2021.27.2.223","article-title":"Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder","volume":"27","author":"JT Ta","year":"2021","journal-title":"Journal of managed care & specialty pharmacy"},{"issue":"4","key":"pone.0269836.ref074","doi-asserted-by":"crossref","first-page":"e027049","DOI":"10.1136\/bmjopen-2018-027049","article-title":"Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review","volume":"9","author":"F Fatoye","year":"2019","journal-title":"BMJ open"},{"issue":"8","key":"pone.0269836.ref075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","article-title":"A systematic review of persistence and compliance with bisphosphonates for osteoporosis","volume":"18","author":"JA Cramer","year":"2007","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"4","key":"pone.0269836.ref076","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/03007995.2017.1281109","article-title":"A systematic review to assess adherence and persistence with statins.","volume":"33","author":"S Deshpande","year":"2017","journal-title":"Current Medical Research and Opinion"},{"key":"pone.0269836.ref077","author":"DP Nau","year":"2012"},{"issue":"4","key":"pone.0269836.ref078","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.amjmed.2012.09.004","article-title":"The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review","volume":"126","author":"A Bitton","year":"2013","journal-title":"The American journal of medicine"},{"key":"pone.0269836.ref079","article-title":"International comparisons of health care prices from the 2017 iFHP survey","author":"J Hargraves","year":"2019"},{"issue":"6","key":"pone.0269836.ref080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40266-013-0074-z","article-title":"Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature","volume":"30","author":"EL Sattler","year":"2013","journal-title":"Drugs & aging"},{"issue":"3","key":"pone.0269836.ref081","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40273-017-0597-y","article-title":"Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases","volume":"36","author":"MV Bjarnadottir","year":"2018","journal-title":"PharmacoEconomics"},{"issue":"2","key":"pone.0269836.ref082","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S0266462312000086","article-title":"The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies.","volume":"28","author":"A Morrison","year":"2012","journal-title":"International journal of technology assessment in health care"},{"issue":"9","key":"pone.0269836.ref083","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0895-4356(00)00188-8","article-title":"What contributions do languages other than English make on the results of meta-analyses?","volume":"53","author":"D Moher","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"pone.0269836.ref084","first-page":"105","article-title":"The association of antidepressant medication adherence with employee disability absences","volume":"13","author":"WN Burton","year":"2007","journal-title":"The American journal of managed care"},{"issue":"12","key":"pone.0269836.ref085","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.clinthera.2011.10.021","article-title":"Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy","volume":"33","author":"SW Wade","year":"2011","journal-title":"Clin Ther"},{"issue":"6","key":"pone.0269836.ref086","doi-asserted-by":"crossref","DOI":"10.1097\/JOM.0b013e318223470b","article-title":"Medication Adherence, Comorbidities, and Health Risk Impacts on Workforce Absence and Job Performance","volume":"53","author":"R Loeppke","year":"2011","journal-title":"Journal of occupational and environmental medicine"},{"issue":"7","key":"pone.0269836.ref087","doi-asserted-by":"crossref","DOI":"10.1097\/JOM.0b013e31825463e9","article-title":"Impact of Medication Adherence on Absenteeism and Short-Term Disability for Five Chronic Diseases","volume":"54","author":"GS Carls","year":"2012","journal-title":"Journal of occupational and environmental medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T17:24:22Z","timestamp":1656523462000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269836"}},"subtitle":[],"editor":[{"given":"Daoud","family":"Al-Badriyeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":87,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0269836","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}